Inventor
BARNETT SUSAN W
US15 patents
⚠️ This page may combine multiple inventors who share the name “BARNETT SUSAN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BARNETT SUSAN W
4 patentsUS8541230B2Sep 24, 2013
Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
BARNETT SUSAN W3 citations60
US8168418B2May 1, 2012
Expression of HIV polypeptides and production of virus-like particles
BARNETT SUSAN W2 citations59
US8470334B2Jun 25, 2013
Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics
BARNETT SUSAN W0 citations48
US8226955B2Jul 24, 2012
Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
BARNETT SUSAN W0 citations48
NOVARTIS VACCINES & DIAGNOSTIC
3 patentsUS7943375B2May 17, 2011
Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
NOVARTIS VACCINES & DIAGNOSTIC3 citations61
US7622125B2Nov 24, 2009
Polycistronic HIV vector constructs
NOVARTIS VACCINES & DIAGNOSTIC2 citations61
US7718401B2May 18, 2010
Expression of HIV polypeptides and production of virus-like particles
NOVARTIS VACCINES & DIAGNOSTIC0 citations50
MASIGNANI VEGA
2 patentsUS8206720B2Jun 26, 2012
Fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutraliziation epitopes
MASIGNANI VEGA2 citations60
US8568734B2Oct 29, 2013
Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes
MASIGNANI VEGA1 citations49